These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20553921)

  • 1. Cyclosporin A induces hyperpermeability of the blood-brain barrier by inhibiting autocrine adrenomedullin-mediated up-regulation of endothelial barrier function.
    Dohgu S; Sumi N; Nishioku T; Takata F; Watanabe T; Naito M; Shuto H; Yamauchi A; Kataoka Y
    Eur J Pharmacol; 2010 Oct; 644(1-3):5-9. PubMed ID: 20553921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autocrine and paracrine up-regulation of blood-brain barrier function by plasminogen activator inhibitor-1.
    Dohgu S; Takata F; Matsumoto J; Oda M; Harada E; Watanabe T; Nishioku T; Shuto H; Yamauchi A; Kataoka Y
    Microvasc Res; 2011 Jan; 81(1):103-7. PubMed ID: 21036181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide mediates cyclosporine-induced impairment of the blood-brain barrier in cocultures of mouse brain endothelial cells and rat astrocytes.
    Dohgu S; Yamauchi A; Nakagawa S; Takata F; Kai M; Egawa T; Naito M; Tsuruo T; Sawada Y; Niwa M; Kataoka Y
    Eur J Pharmacol; 2004 Nov; 505(1-3):51-9. PubMed ID: 15556136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin induces up-regulation of blood-brain barrier functions by activating AMP-activated protein kinase in rat brain microvascular endothelial cells.
    Takata F; Dohgu S; Matsumoto J; Machida T; Kaneshima S; Matsuo M; Sakaguchi S; Takeshige Y; Yamauchi A; Kataoka Y
    Biochem Biophys Res Commun; 2013 Apr; 433(4):586-90. PubMed ID: 23523792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.
    Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M
    Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluvastatin prevents glutamate-induced blood-brain-barrier disruption in vitro.
    Kuhlmann CR; Gerigk M; Bender B; Closhen D; Lessmann V; Luhmann HJ
    Life Sci; 2008 Jun; 82(25-26):1281-7. PubMed ID: 18534629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thr(207) of claudin-5 is involved in size-selective loosening of the endothelial barrier by cyclic AMP.
    Soma T; Chiba H; Kato-Mori Y; Wada T; Yamashita T; Kojima T; Sawada N
    Exp Cell Res; 2004 Oct; 300(1):202-12. PubMed ID: 15383327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hypoxia on endothelial/pericytic co-culture model of the blood-brain barrier.
    Hayashi K; Nakao S; Nakaoke R; Nakagawa S; Kitagawa N; Niwa M
    Regul Pept; 2004 Dec; 123(1-3):77-83. PubMed ID: 15518896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability.
    Stamatovic SM; Shakui P; Keep RF; Moore BB; Kunkel SL; Van Rooijen N; Andjelkovic AV
    J Cereb Blood Flow Metab; 2005 May; 25(5):593-606. PubMed ID: 15689955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a humanized in vitro blood-brain barrier model to screen for brain penetration of antiepileptic drugs.
    Cucullo L; Hossain M; Rapp E; Manders T; Marchi N; Janigro D
    Epilepsia; 2007 Mar; 48(3):505-16. PubMed ID: 17326793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluvastatin stabilizes the blood-brain barrier in vitro by nitric oxide-dependent dephosphorylation of myosin light chains.
    Kuhlmann CR; Lessmann V; Luhmann HJ
    Neuropharmacology; 2006 Sep; 51(4):907-13. PubMed ID: 16872642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse effect of cyclosporin A on barrier functions of cerebral microvascular endothelial cells after hypoxia-reoxygenation damage in vitro.
    Dohgu S; Nishioku T; Sumi N; Takata F; Nakagawa S; Naito M; Tsuruo T; Yamauchi A; Shuto H; Kataoka Y
    Cell Mol Neurobiol; 2007 Nov; 27(7):889-99. PubMed ID: 17934807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood-brain barrier.
    Wong D; Dorovini-Zis K; Vincent SR
    Exp Neurol; 2004 Dec; 190(2):446-55. PubMed ID: 15530883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenomedullin enhances baroreceptor reflex response via cAMP/PKA signaling in nucleus tractus solitarii of rats.
    Ho LK; Chen K; Ho IC; Shen YC; Yen DH; Li FC; Lin YC; Kuo WK; Lou YJ; Yen JC
    Neuropharmacology; 2008 Oct; 55(5):729-36. PubMed ID: 18616957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial hepatectomy aggravates cyclosporin A-induced neurotoxicity by lowering the function of the blood-brain barrier in mice.
    Yamauchi A; Dohgu S; Takata F; Watanabe T; Nishioku T; Matsumoto J; Ohkubo Y; Shuto H; Kataoka Y
    Life Sci; 2011 Mar; 88(11-12):529-34. PubMed ID: 21262237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glial induction of blood-brain barrier-like L-system amino acid transport in the ECV304 cell line.
    Chishty M; Reichel A; Begley DJ; Abbott NJ
    Glia; 2002 Aug; 39(2):99-104. PubMed ID: 12112361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential susceptibility of cerebral and cerebellar murine brain microvascular endothelial cells to loss of barrier properties in response to inflammatory stimuli.
    Silwedel C; Förster C
    J Neuroimmunol; 2006 Oct; 179(1-2):37-45. PubMed ID: 16884785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A functional in vitro model of rat blood-brain barrier for molecular analysis of efflux transporters.
    Perrière N; Yousif S; Cazaubon S; Chaverot N; Bourasset F; Cisternino S; Declèves X; Hori S; Terasaki T; Deli M; Scherrmann JM; Temsamani J; Roux F; Couraud PO
    Brain Res; 2007 May; 1150():1-13. PubMed ID: 17434463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the chemokine CCL2 on blood-brain barrier permeability during ischemia-reperfusion injury.
    Dimitrijevic OB; Stamatovic SM; Keep RF; Andjelkovic AV
    J Cereb Blood Flow Metab; 2006 Jun; 26(6):797-810. PubMed ID: 16192992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MK801 blocks hypoxic blood-brain-barrier disruption and leukocyte adhesion.
    Kuhlmann CR; Zehendner CM; Gerigk M; Closhen D; Bender B; Friedl P; Luhmann HJ
    Neurosci Lett; 2009 Jan; 449(3):168-72. PubMed ID: 18996441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.